New Products: Quofenix (delafloxacin meglumine) 450mg tablets and powder for concentrate for solution for infusion

Delafloxacin meglumine is licensed for treatment of acute bacterial skin and skin structure infections in adults when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections.


electronic Medicines compendium